These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31397095)

  • 1. Weight loss in heart failure is associated with increased mortality only in non-obese patients without diabetes.
    Niedziela JT; Hudzik B; Strojek K; Poloński L; Gąsior M; Rozentryt P
    J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1307-1315. PubMed ID: 31397095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight Loss in Obese Patients With Heart Failure.
    Zamora E; Díez-López C; Lupón J; de Antonio M; Domingo M; Santesmases J; Troya MI; Díez-Quevedo C; Altimir S; Bayes-Genis A
    J Am Heart Assoc; 2016 Mar; 5(3):e002468. PubMed ID: 27013541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of weight loss in patients with heart failure with preserved ejection fraction: results from the FLAGSHIP study.
    Kamisaka K; Kamiya K; Iwatsu K; Iritani N; Imoto S; Adachi T; Iida Y; Yamada S;
    ESC Heart Fail; 2021 Dec; 8(6):5293-5303. PubMed ID: 34599855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between body mass index and survival in Taiwanese heart failure patients with and without diabetes mellitus.
    Lu YY; Wu VCC; Chu PH; Ho CT; Chang CY
    Medicine (Baltimore); 2021 Dec; 100(48):e28114. PubMed ID: 35049240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No benefit from the obesity paradox for diabetic patients with heart failure.
    Zamora E; Lupón J; Enjuanes C; Pascual-Figal D; de Antonio M; Domingo M; Comín-Colet J; Vila J; Peñafiel J; Farré N; Alonso N; Santesmases J; Troya M; Bayés-Genís A
    Eur J Heart Fail; 2016 Jul; 18(7):851-8. PubMed ID: 27312985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of weight loss in heart failure patients with overweight and obesity: a systematic review and meta-analysis.
    Chi M; Nie Y; Su Y; Wang N; Li A; Ma T; Hou Y
    Eur J Prev Cardiol; 2023 Nov; 30(17):1906-1921. PubMed ID: 37652032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus.
    Fröhlich H; Bossmeyer A; Kazmi S; Goode KM; Agewall S; Atar D; Grundtvig M; Frey N; Cleland JGF; Frankenstein L; Clark AL; Täger T
    Clin Res Cardiol; 2024 Jun; 113(6):822-830. PubMed ID: 37608126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction.
    Tromp J; Lim SL; Tay WT; Teng TK; Chandramouli C; Ouwerkerk W; Wander GS; Sawhney JPS; Yap J; MacDonald MR; Ling LH; Sattar N; McMurray JJV; Richards AM; Anand I; Lam CSP;
    Diabetes Care; 2019 Sep; 42(9):1792-1799. PubMed ID: 31292141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of diabetes and sex in heart failure with reduced ejection fraction patients from the ASIAN-HF registry.
    Chandramouli C; Teng TK; Tay WT; Yap J; MacDonald MR; Tromp J; Yan L; Siswanto B; Reyes EB; Ngarmukos T; Yu CM; Hung CL; Anand I; Richards AM; Ling LH; Regensteiner JG; Lam CSP;
    Eur J Heart Fail; 2019 Mar; 21(3):297-307. PubMed ID: 30548089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study.
    Adamopoulos C; Meyer P; Desai RV; Karatzidou K; Ovalle F; White M; Aban I; Love TE; Deedwania P; Anker SD; Ahmed A
    Eur J Heart Fail; 2011 Feb; 13(2):200-6. PubMed ID: 20930001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-ethnic comparisons of diabetes in heart failure with reduced ejection fraction: insights from the HF-ACTION trial and the ASIAN-HF registry.
    Cooper LB; Yap J; Tay WT; Teng TK; MacDonald M; Anand IS; Sharma A; O'Connor CM; Kraus WE; Mentz RJ; Lam CS;
    Eur J Heart Fail; 2018 Sep; 20(9):1281-1289. PubMed ID: 29943890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction: a prospective five-year study.
    Tribouilloy C; Rusinaru D; Mahjoub H; Tartière JM; Kesri-Tartière L; Godard S; Peltier M
    Heart; 2008 Nov; 94(11):1450-5. PubMed ID: 18208832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of diabetes on the predictive value of heart failure biomarkers.
    Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
    Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction.
    Parrinello G; Torres D; Buscemi S; Di Chiara T; Cuttitta F; Cardillo M; Pluchinotta FR; Scaglione R; Paterna S; Pinto A
    Intern Emerg Med; 2019 Oct; 14(7):1091-1100. PubMed ID: 30895427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity Paradox among Heart Failure with Reduced Ejection Fraction Patients: A Retrospective Cohort Study.
    Alrob OA; Sankaralingam S; Alazzam S; Nusairat B; Qattoum M; Nusair MB
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
    Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G
    JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial.
    Sharma A; Ambrosy AP; DeVore AD; Margulies KB; McNulty SE; Mentz RJ; Hernandez AF; Michael Felker G; Cooper LB; Lala A; Vader J; Groake JD; Borlaug BA; Velazquez EJ
    ESC Heart Fail; 2018 Dec; 5(6):1035-1043. PubMed ID: 30120812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of heart failure on prognosis of diabetic and non-diabetic patients with myocardial infarction: a 15-year follow-up study.
    Melchior T; Rask-Madsen C; Torp-Pedersen C; Hildebrandt P; Køber L; Jensen G
    Eur J Heart Fail; 2001 Jan; 3(1):83-90. PubMed ID: 11163740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.